Fosinopril Impurity 4 | CAS 103201-78-1 - Request Quote
Fosinopril Impurity 4
| SZ CAT No: | SZ-F022023 |
| CAS No | 103201-78-1 |
| Mol.F. | C11H19NO2 |
| Mol.Wt. | 197.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 90657-55-9 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Fosinopril Impurity 4 is chemically (2S,4S)-4-cyclohexylpyrrolidine-2-carboxylic acid. Fosinopril Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Fosinopril Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fosinopril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 103201-78-1
Purchase 103201-78-1
Order 103201-78-1
Enquire 103201-78-1
price of 103201-78-1
103201-78-1 Supplier
103201-78-1 Manufacturer
103201-78-1 Exporter
buy high quality Fosinopril Impurity 4
Purchase Fosinopril Impurity 4
Fosinopril Impurity 4 suppliers
Fosinopril Impurity 4 manufacturers
Fosinopril Impurity 4 price
Order Fosinopril Impurity 4
Enquire Fosinopril Impurity 4
Fosinopril Impurity 4 cost
Fosinopril Impurity 4 Supplier
Fosinopril Impurity 4 Distributor
Fosinopril Impurity 4 for Method Validation
Fosinopril Reference Standard
Fosinopril Impurity 4 for ANDA Filing
Fosinopril Impurity 4 for Forced Degradation Studies
Fosinopril Impurity 4 Identification Standards
Fosinopril Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


